Skip to main content
Journal of Patient-Reported Outcomes
Fig. 8 | Journal of Patient-Reported Outcomes

Fig. 8

From: Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

Fig. 8

Change from baseline in SNOT-22 total and domain scores at Week 52. Estimates are based on weighting applied to each level of class variable determined from observed proportions. CI confidence interval, LS Least squares, SC Subcutaneous, SE Standard error, SNOT-22 Sino-nasal outcome test-22

Back to article page